Medicines and clinical research approved in 2023

Approval Table ANVISA 2023

Medicines and clinical research approved in 2023

In 2023, Anvisa stepped up drug approvals, modernized regulations, implemented the QMS, prepared for WHO evaluation with the GBT and increased regulatory publications. Read more here

ELS can help you get your products on these charts! Count on us for registration and all the support you need for medicines.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.